MEPROBAMATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for meprobamate and what is the scope of patent protection?
Meprobamate
is the generic ingredient in nine branded drugs marketed by Medpointe Pharm Hlc, Wyeth Ayerst, Ferndale Labs, Alra, Teva, Acella, Alembic Pharms Ltd, Barr, Chartwell Molecular, Elkins Sinn, Heather, Impax Labs, Invagen Pharms, Ivax Sub Teva Pharms, Lederle, Lee Km, Mallard, Mk Labs, Mylan, Nexgen Pharma Inc, Parke Davis, Perrigo, Pharmavite, Purepac Pharm, Pvt Form, Rising, Roxane, Sandoz, Scherer Labs, Solvay, Stanlabs Pharm, Sun Pharm Industries, Tablicaps, Taro, Usl Pharma, Valeant Pharm Intl, Vangard, Watson Labs, West Ward, Whiteworth Town Plsn, and Halsey, and is included in fifty-seven NDAs. Additional information is available in the individual branded drug profile pages.There are twenty-two drug master file entries for meprobamate. Four suppliers are listed for this compound.
Summary for MEPROBAMATE
| US Patents: | 0 |
| Tradenames: | 9 |
| Applicants: | 41 |
| NDAs: | 57 |
| Drug Master File Entries: | 22 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 41 |
| Patent Applications: | 6,565 |
| Drug Prices: | Drug price trends for MEPROBAMATE |
| What excipients (inactive ingredients) are in MEPROBAMATE? | MEPROBAMATE excipients list |
| DailyMed Link: | MEPROBAMATE at DailyMed |
Medical Subject Heading (MeSH) Categories for MEPROBAMATE
Anatomical Therapeutic Chemical (ATC) Classes for MEPROBAMATE
US Patents and Regulatory Information for MEPROBAMATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solvay | TRANMEP | meprobamate | TABLET;ORAL | 016249-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alembic Pharms Ltd | MEPROBAMATE | meprobamate | TABLET;ORAL | 090122-001 | Feb 18, 2009 | AA | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sandoz | MEPROBAMATE | meprobamate | TABLET;ORAL | 014547-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Perrigo | MEPROBAMATE | meprobamate | TABLET;ORAL | 084547-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| West Ward | MEPROBAMATE | meprobamate | TABLET;ORAL | 015417-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Solvay | TRANMEP | meprobamate | TABLET;ORAL | 084369-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Scherer Labs | MEPROBAMATE | meprobamate | TABLET;ORAL | 083343-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
